(MT Newswires) -- Stéphane Bancel, CEO of Moderna, wants to restore confidence in the vaccines sector. He advocates less dogmatic and more humble scientific communication, recognising that science is constantly evolving. Bancel emphasises the importance of relying on reliable, objective data to educate the public and combat misinformation. He expresses reservations about early official communications that discouraged the use of masks, believing that this eroded confidence in the health authorities. Bancel also challenges the perception that vaccines are less profitable than other treatments, citing the financial success of innovative vaccines such as Merck's HPV vaccine and GSK's Shingrix.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
124.4 USD | +2.05% | -1.05% | +24.96% |
May. 07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.96% | 46.71B | |
+48.83% | 41.8B | |
-1.21% | 41.52B | |
-5.86% | 29.55B | |
+10.35% | 25.78B | |
-20.80% | 19.26B | |
+2.01% | 12.14B | |
-3.33% | 12.08B | |
+28.52% | 11.98B | |
+20.35% | 11.58B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector